Anbio Biotechnology

NNNN ·Healthcare, Drug Manufacturers - General, Germany
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $30.2M

Liabilities Breakdown FY2025

Total Liabilities: $87.8K